BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28646473)

  • 21. Advantage of FISH analysis using FKHR probes for an adjunct to diagnosis of rhabdomyosarcomas.
    Matsumura T; Yamaguchi T; Seki K; Shimoda T; Wada T; Yamashita T; Hasegawa T
    Virchows Arch; 2008 Mar; 452(3):251-8. PubMed ID: 18094995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alveolar rhabdomyosarcoma: novel surrogate markers associated with oncogenic translocation].
    Tarakanova AV; Sharlay AS; Konovalov DM
    Arkh Patol; 2023; 85(1):10-15. PubMed ID: 36785957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers.
    Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A;
    Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.
    Hingorani P; Missiaglia E; Shipley J; Anderson JR; Triche TJ; Delorenzi M; Gastier-Foster J; Wing M; Hawkins DS; Skapek SX
    Clin Cancer Res; 2015 Oct; 21(20):4733-9. PubMed ID: 26473193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
    Kouraklis G; Triche TJ; Wesley R; Tsokos M
    Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
    Anderson J; Gordon T; McManus A; Mapp T; Gould S; Kelsey A; McDowell H; Pinkerton R; Shipley J; Pritchard-Jones K;
    Br J Cancer; 2001 Sep; 85(6):831-5. PubMed ID: 11556833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult Primary Pineal Alveolar Rhabdomyosarcoma with FOXO1 Gene Rearrangement and OLIG2 Expression: A Rare Case Report and Literature Review.
    Xie L; Wang W; Zhou H; Han Z; Xu J; Xu Z; Xiang J
    Int J Surg Pathol; 2022 Oct; 30(7):769-775. PubMed ID: 35188829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features.
    Hachitanda Y; Toyoshima S; Akazawa K; Tsuneyoshi M
    Mod Pathol; 1998 Dec; 11(12):1222-7. PubMed ID: 9872655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma.
    Liu J; Guzman MA; Pezanowski D; Patel D; Hauptman J; Keisling M; Hou SJ; Papenhausen PR; Pascasio JM; Punnett HH; Halligan GE; de Chadarévian JP
    Mod Pathol; 2011 Oct; 24(10):1327-35. PubMed ID: 21666686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Gallego S; Zanetti I; Orbach D; Ranchère D; Shipley J; Zin A; Bergeron C; de Salvo GL; Chisholm J; Ferrari A; Jenney M; Mandeville HC; Rogers T; Merks JHM; Mudry P; Glosli H; Milano GM; Ferman S; Bisogno G;
    Cancer; 2018 Aug; 124(15):3201-3209. PubMed ID: 29797665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic Characterization of a Metastatic Alveolar Rhabdomyosarcoma Case Using FISH Studies and CGH+SNP Microarray Revealing FOXO1-PAX7 Rearrangement with MYCN and MDM2 Amplification and RB1 Region Loss.
    Karunamurthy A; Hoffner L; Hu J; Shaw P; Ranganathan S; Yatsenko SA; Surti U
    Cytogenet Genome Res; 2016; 150(3-4):253-261. PubMed ID: 28253504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.
    Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR
    Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evidence of genetic alterations in chromosome 11 in embryonal and alveolar rhabdomyosarcoma].
    Brinkschmidt C; Poremba C; Schäfer KL; Simon R; Jürgens H; Böcker W; Dockhorn-Dworniczak B
    Verh Dtsch Ges Pathol; 1998; 82():210-4. PubMed ID: 10095436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
    Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
    Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaplastic lymphoma kinase status in rhabdomyosarcomas.
    Yoshida A; Shibata T; Wakai S; Ushiku T; Tsuta K; Fukayama M; Makimoto A; Furuta K; Tsuda H
    Mod Pathol; 2013 Jun; 26(6):772-81. PubMed ID: 23307059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
    Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
    Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma.
    Cerveira N; Torres L; Ribeiro FR; Henrique R; Pinto A; Bizarro S; Ferreira AM; Lopes C; Teixeira MR
    Cancer Genet Cytogenet; 2005 Dec; 163(2):138-43. PubMed ID: 16337856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma.
    Oda Y; Kohashi K; Yamamoto H; Tamiya S; Kohno K; Kuwano M; Iwamoto Y; Tajiri T; Taguchi T; Tsuneyoshi M
    Cancer Sci; 2008 Apr; 99(4):726-32. PubMed ID: 18377424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptic insertion of 3'FOXO1 into inverted chromosome arm 2q in the presence of two normal chromosome 13s and 13 small interstitial duplications in a patient with alveolar rhabdomyosarcoma.
    Hackman S; Calvey L; Bernreuter K; Mark MW; Starnes S; Batanian JR
    Cancer Genet; 2015 Sep; 208(9):428-33. PubMed ID: 26316324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.